Literature DB >> 15300211

Gallbladder myocytes are short and cholecystokinin-resistant in obese diabetic mice.

Shannon J Graewin1, Keun-Ho Lee, James M Kiely, Carol L Svatek, Attila Nakeeb, Henry A Pitt.   

Abstract

BACKGROUND: Obesity is associated with diabetes and gallstone formation. Obese leptin-deficient (Lepob) and leptin-resistant (Lepdb) mice are hyperglycemic and have enlarged gallbladders with diminished response in vitro to cholecystokinin (CCK) and acetylcholine (ACh). Whether this phenomenon is secondary to hyperosmolar myocytes and/or decreased neuromuscular transmission remains unclear. We hypothesize that myocytes from Lepob and Lepdb obese mice would not respond normally to neurotransmitters.
METHODS: Cholecystectomy was performed on 39 lean, 19 Lepob, and 20 Lepdb 12-week-old female mice. The gallbladder was divided and enzymatically digested. Half of each gallbladder's myocytes had contraction induced by CCK (10(-8) mol/L, n = 38) or ACh (10(-5) mol/L, n = 40).
RESULTS: Body weights, gallbladder volumes, and serum glucoses were greater for Lep(ob) and Lepdb mice compared to controls (P < .001). Resting myocyte lengths from Lepob and Lepdb mice were 93% and 91% of the length of controls (P < .001). In response to CCK, lean myocytes shortened 6% (P < .01), while myocytes from obese mice demonstrated no shortening. None of the myocytes demonstrated significant shortening with ACh.
CONCLUSIONS: These data suggest that gallbladder myocytes from obese mice are (1) foreshortened and (2) have a diminished response to cholecystokinin. We conclude that altered leptin and/or increased glucose may foreshorten myocytes and decrease response to cholecystokinin. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15300211     DOI: 10.1016/j.surg.2004.05.020

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

1.  In vivo magnetic resonance imaging to detect biliary excretion of 19F-labeled drug in mice.

Authors:  Jean-Pierre Raufman; Su Xu; Kunrong Cheng; Sandeep Khurana; Diana Johnson; Changxing Shao; Maureen A Kane; Da Shi; Rao Gullapalli; James Polli
Journal:  Drug Metab Dispos       Date:  2011-01-26       Impact factor: 3.922

2.  Resistin-like molecule alpha reduces gallbladder optimal tension.

Authors:  Hayder H Al-Azzawi; Abhishek Mathur; Debao Lu; Deborah A Swartz-Basile; Attila Nakeeb; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2007-01       Impact factor: 3.452

3.  Disruption of the murine protein kinase Cbeta gene promotes gallstone formation and alters biliary lipid and hepatic cholesterol metabolism.

Authors:  Wei Huang; Rishipal R Bansode; Yan Xie; Leslie Rowland; Madhu Mehta; Nicholas O Davidson; Kamal D Mehta
Journal:  J Biol Chem       Date:  2011-05-05       Impact factor: 5.157

4.  Nonalcoholic Fatty gallbladder disease: the influence of diet in lean and obese mice.

Authors:  Matthew I Goldblatt; Deborah A Swartz-Basile; Hayder H Al-Azzawi; Khoi Q Tran; Attila Nakeeb; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

5.  Nonobese diabetic mice have diminished gallbladder motility and shortened crystal observation time.

Authors:  Shannon J Graewin; James M Kiely; Keun-Ho Lee; Carol L Svatek; Attila Nakeeb; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

6.  Insulin resistance causes human gallbladder dysmotility.

Authors:  Attila Nakeeb; Anthony G Comuzzie; Hayder Al-Azzawi; Gabriele E Sonnenberg; Ahmed H Kissebah; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2006 Jul-Aug       Impact factor: 3.452

7.  Biliary lipids and cholesterol crystal formation in leptin-deficient obese mice.

Authors:  Deborah A Swartz-Basile; Matthew I Goldblatt; Seong Ho Choi; Carol Svatek; Khoi Tran; Attila Nakeeb; Henry A Pitt
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

8.  Diminished gallbladder motility in Rotund leptin-resistant obese mice.

Authors:  Shannon J Graewin; Khoi Q Tran; Jurgen K Naggert; Keun-Ho Lee; Debbie Swartz-Basile; Attila Nakeeb; Henry A Pitt
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.